Menu Back to 6th-DIA-Cell-and-Gene-Therapy-Products-Symposium-in-Japan


6th DIA Cell and Gene Therapy Products Symposium in Japan
 “Mastering Regenerative Medicine in Clinical Practice: Solving Issues at the Industrial Stage”

Click Here to View the Program



Who should attend?

Cell therapy/gene therapy product development professionals in biopharmaceutical companies, medical devices companies, venture capital companies, regulatory agencies, or academia.

Program Committee

  • Yoji  Sato, PhD
    Yoji Sato, PhD Head, Division of Cell-Based Therapeutic Products
    National Institute of Health Sciences, Japan
  • Yasuko  Terao, PhD
    Yasuko Terao, PhD Director, External Collaboration and Portfolio Management Department
    Janssen Pharmaceutical K.K., Japan
  • Teruyo  Arato, PhD
    Teruyo Arato, PhD Professor, Clinical Research and Medical Innovation Center
    Hokkaido University Hospital, Japan
  • Masaki  Kasai, PhD
    Masaki Kasai, PhD Principal Reviewer, Office of Cellular and Tissue-basaed Products
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Satoru  Hayata, MS
    Satoru Hayata, MS
    Sobi Japan, Japan
  • Sumimasa  Nagai, MD, PhD
    Sumimasa Nagai, MD, PhD Institute for Advancement of Clinical and Translational Science(iACT)
    Kyoto University Hospital, Japan
  • Hiromi  Okabe, PhD
    Hiromi Okabe, PhD Manager, Global Regulatory Management Group, New Drug Regulatory Affairs Dept.
    Daiichi Sankyo Co., Ltd., Japan
  • Kazunobu  Oyama, PhD
    Kazunobu Oyama, PhD
    Daiichi Sankyo Co., Ltd., Japan
  • Masafumi  Onodera, MD, PhD
    Masafumi Onodera, MD, PhD Head, Department of Human Genetics / Chief, Division of Immunology
    National Center for Child Health and Development, Japan
  • Hiroyuki  Suda, MSc
    Hiroyuki Suda, MSc VP, Clinical Development Strategy
    KORTUC Inc., Japan
  • Yoshie  Tsurumaki
    Yoshie Tsurumaki Group Manager, Cell & Gene Franchise
    Novartis Pharma K.K., Japan
  • Akiko  Ikeda, RPh
    Akiko Ikeda, RPh Associate Director, Regulatory Development Dept., Regulatory Affairs Division,
    Janssen Pharmaceutical K.K., Japan
Load More

Contact us

Please contact DIA Japan for further information.

Send Email

Digital Learning Catalog

DIA Learning: eLearning Soultions